Spheroid & Organoid Quantification
- 3D segmentation of spheroids and organoids
- Morphological characterization
- Volume and shape analysis
- Multi-channel quantification
Expertise · Oncology
Oncology & Complex 3D Cell Models
Quantitative analysis of cancer models, spheroids, organoids, multicellular systems and organs for translational and preclinical research.
Key services
What we deliver for oncology teams
Quantitative endpoints for 3D cancer models, organoids, and translational oncology studies — designed for screening, mechanism, and efficacy evaluation.
Cell Population Analysis
- Total cell counting
- Nuclear and cytoplasmic labeling quantification
- Cell ratio computation
- Heterogeneity analysis
Spatial Distribution & Penetration Analysis
- Molecule penetration analysis in 3D samples
- Drug diffusion characterization
- Spatial biomarker distribution analysis
- Gradient quantification
Longitudinal & Temporal Analysis
- Organoid growth tracking over time
- Dynamic fluorescence quantification
- Treatment response monitoring
- Time-lapse image analysis
- Classification and anomaly detection
Typical applications
Where this expertise is applied
Applications
- Drug screening
- Tumor microenvironment studies
- Patient-derived organoids
- Cancer biomarker analysis
- Preclinical therapeutic evaluation
Working on spheroids, organoids or tumor models?
From drug screening to patient-derived organoids, we build pipelines that produce reproducible, biologically meaningful endpoints.